| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2019 - 2023 |
| CAGR | 7.30 % |
| Fastest Growing Market | North America |
| Largest Market | Asia Pacific |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Tonsil & Adenoid Removal Products Market Analysis
The Tonsil and Adenoid Removal Products Market is expected to register a CAGR of 7.3% during the forecast period.
The COVID-19 pandemic has had a substantial impact on the tonsil & adenoid removal products market initially. The imposition of lockdown and delay of non-urgent surgeries and non-COVID disease treatment decreased the number of tonsil and adenoid procedures in 2020. The high risk of COVID-19 led to prioritizing only critical surgeries and procedures, which restricted various otolaryngology services. For instance, in a study published in the Journal of Head and Neck in February 2022, the number of tonsil surgery decreased by up to 82% in Germany due to the pandemic. According to a study published in the Journal Laryngoscope Investigative Otolaryngology in July 2021, along with the delay and cancellation of elective surgeries during a pandemic. The COVID-19 lockdown decreased the incidence rates of tonsil infections, such as in children, which also led to a decrease in the volume of tympanostomies and tonsil surgeries in children. However, even during the pandemic, severe cases of tonsil surgeries were allowed and performed. For instance, in a study published in the European Annals of Otorhinolaryngology, Head and Neck Diseases in May 2020, tonsillectomy and adenoidectomy were performed without any delay in the case of severe obstructive sleep apnea syndrome in adults. Although, with the lifting of the lockdown and the resumption of the non-COVID, non-urgent, and elective procedures, the market is expected to regain its normal pace as it was in pre-COVID. For instance, in February 2022, the New South Wales Government announced the resumption of non-urgent elective surgeries and increased the overnight stay of the patients by 85% of pre-pandemic activity levels in the private hospitals. Further, in May 2022, the New York State Department of Health (DOH) announced the updated guideline for the resumption of nonurgent procedures and non-essential elective surgeries in hospitals, office-based surgery practices, diagnostic and treatment centers, and ambulatory surgery centers.
The market is expected to grow further at a stable pace with the lifting of the lockdown and the resumption of the non-COVID, non-urgent, and elective procedures globally.
Further, the increasing cases of tonsil and adenoid infections are also boosting the market's growth. According to a study published in the Lancet in June 2022, the pooled incidence rate of the group A Streptococcus throat infection calculated for children was 82.2 episodes per 100 child years for sore throat and 22.1 episodes per 100 child years for Strep A sore throat. A study published in Journal Nature in December 2022 has underlined the risk of the surging case of strep A after the death of over 13 children in the United Kingdom in the month of December 2022, which causes deadly scarlet fever. According to the STAT Pearls in 2021, the condition of adenoid hypertrophy has a prevalence rate of 34.5% in children.
Therefore, owing to the increasing prevalence of tonsil and adenoid infections, the studied market is anticipated to witness growth over the analysis period. However, the complication associated with the surgeries is likely to impede the market growth.
Tonsil & Adenoid Removal Products Market Trends
The Coblation Segment is Expected to Witness Significant Growth Over the Forecast Period
Coblation, also known as controlled ablation, is a controlled and precise surgical procedure for the removal of the adenoid and tonsil tissue by using low-temperature radiofrequency and a saline solution. The technique has several advantages over traditional adenotonsillectomy procedures. The coblation technique is highly adopted for the management of adenoid and tonsil infections in children because of its advantage of lower bleeding and pain, as compared to traditional adenotonsillectomy procedures. Several studies have supported the safety and efficacy of the technique for tonsil and adenoid procedures, especially in children. According to a study published in the Springer Nature Cureus in March 2022, the coblation technique offers improved outcomes during surgery and post-surgery recovery. The technique caused delayed hemorrhage and post-operative pain after the surgery and offered favorable outcomes in the delivery of analgesia, diet, and tonsillar tissue recovery. A study published in the International Journal of Pediatric Otorhinolaryngology in August 2020 highlighted the safety and efficacy of the coblation intracapsular tonsillectomy for recurrent tonsillitis in children with the condition of obstructive sleep apnea. A study published in Research Square in February 2022 highlighted the safety and efficacy of the coblation technique for adenotonsillar surgery, which reduced self-limited bleeding and controlled blood loss by 0.7%. The procedure also eliminated the need for another tonsillar surgery.
With the desirable post-operative outcome of the coblation technique and its wide usage in pediatric adenoid and tonsil procedures, the segment is expected to witness significant growth over the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Dominate the Outpatient Rehabilitation Centers Market
North America is expected to dominate the market owing to factors such as a high prevalence of tonsil, adenoid, and respiratory infections and a high volume of surgical procedures in the region. The United States has a high burden of respiratory infections as well. According to the National Vital Statistics System - Mortality Data in 2020, over 152,657 deaths happened due to chronic lower respiratory diseases (including asthma). According to the American Lung Association, in November 2022, over 12.5 million adults in the United States are living with the condition of chronic obstructive pulmonary disease. The country has a high volume of surgical procedures of adenoid and tonsil procedures performed every year. According to the National Center for Biotechnology Information, in August 2022, over 500,000 procedures of tonsillectomies were performed every year in the United States. The region also has a high prevalence of respiratory infections which also contributes to the surgical interventions of the tonsil and adenoid organs. According to data published by the CDC in February 2023, over 25 million cases of influenza-associated illnesses, over 280,000 hospitalizations, and 17,000 deaths were reported due to influenza in the United States in the year 2022 and till February 2023. The tonsilitis-causing bacterium Streptococcus pyogenes (group A Streptococcus) affects over 11,000-24,000 individuals, with the Group A streptococcal causing infections such as strep throat and impetigo in the United States each year.
Therefore, owing to the high prevalence of tonsil, adenoid, and respiratory infections, it is expected to boost the growth of the studied market in the North America Region.
Get Analysis on Important Geographic Markets
Download PDF
Tonsil & Adenoid Removal Products Industry Overview
The tonsil & adenoid removal products market is moderately competitive in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of several international as well as local companies which hold market shares and are well known, including Medtronic, BAUSCH & LOMB INCORPORATED, Olympus America, New Med Instruments, medelecsurgical, Smith&Nephew, Advin Health Care, Deluxe Scientific Surgico Pvt Ltd, Integra LifeSciences, and EON Meditech.
Tonsil & Adenoid Removal Products Market Leaders
-
Medtronic
-
BAUSCH & LOMB INCORPORATED
-
Olympus America
-
New Med Instruments
-
medelecsurgical
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Tonsil & Adenoid Removal Products Market News
- September 2022: Olympus America launched its advanced energy device precise dissection equipment, THUNDERBEAT Open Fine Jaw Type X surgical energy devices. It offers fine dissection using advanced bipolar energy.
- February 2022: Pristyn Care, a health technology and secondary-care surgeries start-up, announced that it had increased its surgical centers to 800 in India, in 2021. Pristyn Care surgical centers offer over 12 surgical categories such as General Surgery, ophthalmology, ENT, urology, gynecology, and others. The surgical centre is equipped with Microdebriders, coblators, mini-port laparoscopy kits, and other advanced equipment.
Tonsil & Adenoid Removal Products Industry Segmentation
As per the scope of the report, tonsils and adenoid removal products are used in surgeries related to throat infections. The products help in diagnosing disorders such as sleep apnea and other respiratory tract infections. The Tonsil & Adenoid Removal Products Market is segmented by Type (Tonsils Removal Products (Forceps, Wireloop, and Scissors) and Adenoid Removal Products (Microdebrider)), Technology (Electrocautery (ECT), Coblation, Harmonic Scalpel), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product Type | Tonsils Removal Products | Forceps | |
| Wire loop | |||
| Scissors | |||
| Adenoid Removal Products | Microdebrider | ||
| By Technology | Electrocautery (ECT) | ||
| Coblation | |||
| Harmonic scalpel | |||
| Other Technologies | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Need A Different Region or Segment?
Customize Now
Tonsil & Adenoid Removal Products Market Research FAQs
What is the current Tonsil and Adenoid Removal Products Market size?
The Tonsil and Adenoid Removal Products Market is projected to register a CAGR of 7.3% during the forecast period (2025-2030)
Who are the key players in Tonsil and Adenoid Removal Products Market?
Medtronic, BAUSCH & LOMB INCORPORATED, Olympus America, New Med Instruments and medelecsurgical are the major companies operating in the Tonsil and Adenoid Removal Products Market.
Which is the fastest growing region in Tonsil and Adenoid Removal Products Market?
North America is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Tonsil and Adenoid Removal Products Market?
In 2025, the Asia Pacific accounts for the largest market share in Tonsil and Adenoid Removal Products Market.
What years does this Tonsil and Adenoid Removal Products Market cover?
The report covers the Tonsil and Adenoid Removal Products Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Tonsil and Adenoid Removal Products Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Tonsil and Adenoid Removal Products Industry Report
Statistics for the 2025 Tonsil and Adenoid Removal Products market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Tonsil and Adenoid Removal Products analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
